(RVNC) Revance Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Revance Therapeutics | (RVNC) share price targets
Complete technical analysis of Revance Therapeutics (RVNC) by charts plus indicators, forecast predictions and share price targets for Revance Therapeutics (RVNC)
Revance Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-20 View latest technical analysis
10 day averaged volume of Revance Therapeutics is 5297701
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Fri Dec 2024 | 3.09 | 3.07 | 3.09 | 3.07 | 0.653 times |
| 19 Thu Dec 2024 | 3.07 | 3.09 | 3.09 | 3.07 | 0.749 times |
| 18 Wed Dec 2024 | 3.07 | 3.08 | 3.08 | 3.07 | 0.424 times |
| 17 Tue Dec 2024 | 3.07 | 3.08 | 3.09 | 3.06 | 0.456 times |
| 16 Mon Dec 2024 | 3.09 | 3.08 | 3.09 | 3.08 | 0.797 times |
| 13 Fri Dec 2024 | 3.08 | 3.08 | 3.11 | 3.08 | 0.674 times |
| 12 Thu Dec 2024 | 3.09 | 3.09 | 3.10 | 3.07 | 1.252 times |
| 11 Wed Dec 2024 | 3.04 | 3.02 | 3.04 | 3.02 | 0.517 times |
| 10 Tue Dec 2024 | 3.03 | 3.03 | 3.03 | 3.02 | 0.698 times |
| 09 Mon Dec 2024 | 3.02 | 3.04 | 3.05 | 3.01 | 4.022 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 3 as stoploss in an intra day buy trade for a target of 3.5. However, stock will show a bearish move below 3.
Share price targets for Revance Therapeutics (RVNC)
| Target Type | Value |
| Downside Target | 2.76 |
| Downside Target | 3.01 |
| Upside Target | 3.36 |
| Upside Target | 3.64 |
| Upside Target | 3.87 |
| Upside Target | 4.19 |
| Upside Target | 4.20 |
| Upside Target | 4.68 |
| Upside Target | 5.11 |
| Upside Target | 5.97 |
| Upside Target | 6.09 |
| Upside Target | 6.59 |
| Upside Target | 6.65 |
Intraday share price targets for Revance Therapeutics (RVNC)
| Target Type | Value |
| Downside Intraday Target | 3.07 |
| Downside Intraday Target | 3.05 |
| Upside Intraday Target | 3.1 |
| Upside Intraday Target | 3.11 |
| Downside Intraday Target | 3.08 |
Weekly technical analysis of Revance Therapeutics (RVNC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Fri Dec 2024 | 3.09 | 3.08 | 3.09 | 3.06 | 0.43 times |
| 13 Fri Dec 2024 | 3.08 | 3.04 | 3.11 | 3.01 | 17.444 times |
| 26 Tue Nov 2024 | 4.02 | 3.97 | 4.20 | 3.87 | 0.584 times |
| 26 Tue Nov 2024 | 4.02 | 3.70 | 4.20 | 3.70 | 0.511 times |
| 22 Fri Nov 2024 | 3.73 | 4.18 | 4.19 | 3.64 | 0.415 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Revance Therapeutics (RVNC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Fri Dec 2024 | 3.09 | 3.04 | 3.11 | 3.01 | 1.077 times |
| 26 Tue Nov 2024 | 4.02 | 5.88 | 5.97 | 3.36 | 1.338 times |
| 31 Thu Oct 2024 | 5.90 | 5.23 | 6.09 | 4.68 | 0.36 times |
| 30 Mon Sep 2024 | 5.19 | 6.57 | 6.59 | 5.11 | 0.649 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Revance Therapeutics (RVNC)
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Revance Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Revance Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Revance Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Revance Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Revance Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.05 and Revance Therapeutics (RVNC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Revance Therapeutics (RVNC) stock. Volume based technical analysis of Revance Therapeutics (RVNC) stock is negative.
Revance Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Revance Therapeutics ( (RVNC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Revance Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Revance Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Revance Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Revance Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Revance Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.05 and Revance Therapeutics (RVNC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Revance Therapeutics (RVNC) stock. Volume based technical analysis of Revance Therapeutics (RVNC) stock is negative.
Revance Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.